CD86 and Alzheimer disease: Semaglutide modulates microglial phenotype in 3xTg-AD mice, lowering the Cd86/Cd206 ratio and shifting cytokine expression by reducing Il1b and Tnfa while increasing Il4 and Il10 in the cortex and hippocampus [49].